ArisGlobal Lauded by Frost & Sullivan for Enabling Life Sciences Companies to Accelerate R&D with Its LifeSphere® Platform
Frost & Sullivan
AUGUST 5, 2021
The open architecture of these solutions allows them to integrate with customers’ wider IT ecosystems inside and outside the safety domain. Our end-to-end drug development technology platform, LifeSphere ® , integrates our proprietary cognitive computing engine to automate all core functions of the drug development lifecycle.
52 
Let's personalize your content